NIOSH logo and tagline

Systemic toxicity induced by topical application of heptafluorobutyric acid (PFBA) in a murine model

Updated May 31, 2023

April 2022
NIOSH Dataset RD-1033-2022-0

Introduction

Heptafluorobutyric acid (PFBA) is a synthetic chemical belonging to the per- and polyfluoroalkyl substances (PFAS) group that includes over 5,000 chemicals.  PFBA is a short-chain PFAS (C4) that has been labeled as a safer alternative to the legacy PFAS perfluorooctanoic acid (PFOA) and perfluorooctane sulfate (PFOS) which have been linked to numerous health effects.  This class of chemicals are incorporated into consumer products such as stain resistant carpeting and textiles, nanosprays, medical devices, and fire-fighting foams.  There is a high potential for occupational exposure and in the environment, PFBA has been detected in a variety of water sources leading to concerns for dermal exposure, however, these studies are lacking.  In previous studies from our lab, PFOA was demonstrated to be absorbed via the skin and immunomodulatory.  In the present study, the systemic toxicity of a 28-day dermal PFBA (3.75-15% w/v, or 93.8-375 mg/kg/dose) exposure was evaluated in a murine model.

Data Collection Methods

  1. Animal Exposures
    • Female B6C3F1 mice (7-8 weeks at start of study)
    • Heptafluorobutyric acid (PFBA) (25 µl/ear; 0-15%) or acetone on dorsal surface of both ears for up to 28 days
  2. Tissue Collection
    • Kidney and thymus were collected, weighted, and then discarded.
    • Liver was weighed, (small lobe) was collected in RNA later and then homogenized on a TissueLyser II in Buffer RLT for RNA extraction.  The remainder of the liver was collected in 10% formalin for histopathology analysis.
    • Spleen was weighed, 1/2 was collected in 4 mL RPMI and processed into single cell suspensions by mechanical disruption of tissues between frosted microscope slides.  The remainder of the spleen was collected in 10% formalin for histopathology analysis.
    • Ear pinnas (1 per mouse; split into ventral and dorsal halves) was collected in RPMI and either and processed into single cell suspensions prepared by incubating with a 0.25 mg/ml Liberase-TL Research grade (Roche) enzymatic digestion for 90 min at 37°C in RMPI with 100 µg/ml DNase I.  The second ear pinna (1/2) collected in 10% formalin for histopathology analysis and 1/2 was collected in RNA later and then homogenized on a TissueLyser II in Buffer RLT for RNA extraction.
    • Right and left auricular draining lymph nodes (dLNs) collected in 2 mL sterile phosphate-buffer saline (PBS) (pH 7.4) and single cell suspensions (2 nodes/animal) were prepared by mechanical disruption of tissues between frosted microscope slides
  3. Serum chemistries
    • Blood samples were collected via cardiac puncture and separated by centrifugation.  Selected serum chemistries were evaluated using Catalyst DX Chemistry Analyzer.
  4. Gene expression
    • Real-time PCR (Applied Biosystems 7500 RT-PCR System.
  1. Immune Cell Subsets
    • Flow cytometry using BD LSRII Flow Cytometer and data was analyzed using FlowJo software.
  2. Histology
    • Tissue samples were stained via hematoxylin and eosin (H&E) and evaluated by a veterinary pathologist.

Publications Based on Dataset

Weatherly LM, Shane HL, Lukomska E, Baur R, Anderson SE.  Systemic toxicity induced by topical application of heptafluorobutyric acid (PFBA) in a murine model. Food Chem Toxicol. 2021 Oct;156:112528. doi: 10.1016 /j.fct.2021.112528

Acknowledgements

This project was supported by the National Institute for Occupational Safety and Health (NIOSH). When a publication makes use of this dataset, acknowledgement of the development of the dataset should be attributed to the NIOSH Health Effects Laboratory Division.

We would also like to acknowledge the work of Lisa M. Weatherly, Hillary L. Shane, Ewa Lukomska, Rachel Baur, and Stacey E. Anderson.

Contact

NIOSH/Health Effects Laboratory Division
Allergy and Clinical Immunology Branch
(304) 285-6024